Paxlovid Does Little or Nothing For Covid-19

New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19Show more

“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it seems.”

Paxlovid cost $13.38, according to a Harvard analysis, to produce so Pfizer is profiting majorly off of a drug that essentially does nothing. This is the drug the FDA quickly approved in Dec 2021 "with positive results" while ignoring every study showing strong efficacy via safe, inexpensive and readily available HCQ , Ivermectin.

Chief Nerd on X🔗

Join us👇
@CovidVaccineAdverseReactions